Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2176
First Interstate BancSystem
FIBK
$3.73B
| $2.04M | ﹤0.01% |
65,772
-170,409
| -72% | -$5.2M |
|
|
SFE
2177
DELISTED
Safeguard Scientifics, Inc.
SFE
| $2.03M | ﹤0.01% |
289,417
-63,500
| -18% | -$402K |
|
2178
MediWound
MDWD
$174M
| $2.02M | ﹤0.01% |
97,075
+30,607
| +46% | +$436K |
|
2179
UTStarcom
UTSI
$23.5M
| $2.02M | ﹤0.01% |
287,999
+3,292
| +1% | +$24.4K |
|
2180
iShares Russell Mid-Cap ETF
IWR
$58.4B
| $2.02M | ﹤0.01% |
37,600
+32,800
| +683% | +$1.64M |
|
2181
Protalix BioTherapeutics
PLX
$179M
| $2.01M | ﹤0.01% |
530,434
+53,000
| +11% | +$181K |
|
2182
The Ensign Group
ENSG
$10.6B
| $2.01M | ﹤0.01% |
+48,000
| New | +$1.9M |
|
2183
Patrick Industries
PATK
$2.76B
| $2.01M | ﹤0.01% |
+49,203
| New | +$1.49M |
|
|
CATC
2184
DELISTED
CAMBRIDGE BANCORP
CATC
| $2.01M | ﹤0.01% |
33,873
+990
| +3% | +$52.1K |
|
|
JAX
2185
DELISTED
J. Alexander's Holdings, Inc.
JAX
| $2M | ﹤0.01% |
407,605
-10,900
| -3% | -$49.5K |
|
|
GCP
2186
DELISTED
GCP Applied Technologies Inc.
GCP
| $2M | ﹤0.01% |
107,800
-14,100
| -12% | -$253K |
|
2187
Vanguard Morningstar Mid-Cap ETF
VO
$111B
| $2M | ﹤0.01% |
48,800
+40,400
| +481% | +$1.55M |
|
|
NSTG
2188
DELISTED
NanoString Technologies, Inc.
NSTG
| $2M | ﹤0.01% |
+68,100
| New | +$2.03M |
|
2189
Cumberland Pharmaceuticals
CPIX
$117M
| $2M | ﹤0.01% |
599,458
+127,800
| +27% | +$465K |
|
|
CMCM
2190
Cheetah Mobile
CMCM
$103M
| $1.99M | ﹤0.01% |
231,785
-25,774
| -10% | -$303K |
|
|
AFMD
2191
DELISTED
Affimed
AFMD
| $1.98M | ﹤0.01% |
42,960
+4,760
| +12% | +$132K |
|
|
LADR
2192
Ladder Capital
LADR
$1.27B
| $1.97M | ﹤0.01% |
243,241
-834,500
| -77% | -$6.26M |
|
2193
Penske Automotive Group
PAG
$14.4B
| $1.97M | ﹤0.01% |
+50,800
| New | +$1.77M |
|
|
ASPU
2194
DELISTED
ASPEN GROUP, INC.
ASPU
| $1.96M | ﹤0.01% |
216,967
+133,300
| +159% | +$1.1M |
|
2195
Axcelis
ACLS
$4.33B
| $1.96M | ﹤0.01% |
+70,499
| New | +$1.72M |
|
2196
nVent Electric
NVT
$27.7B
| $1.96M | ﹤0.01% |
+104,441
| New | +$1.9M |
|
2197
Ranpak Holdings
PACK
$478M
| $1.95M | ﹤0.01% |
+262,457
| New | +$1.93M |
|
2198
Century Aluminum
CENX
$4.62B
| $1.95M | ﹤0.01% |
+273,555
| New | +$1.45M |
|
2199
Beazer Homes USA
BZH
$872M
| $1.95M | ﹤0.01% |
193,560
-106,300
| -35% | -$850K |
|
|
GURE
2200
Gulf Resources
GURE
$4.63M
| $1.94M | ﹤0.01% |
36,261
+34
| +0.1% | +$1.54K |
|
Similar funds
Jim Simons's Q2 2020 Portfolio in Review
As of Q2 2020, Jim Simons held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Uber worth $187M.
- Jim Simons's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Jim Simons added most to Zoom in Q2 2020, an estimated $806M increase.
- Jim Simons's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Jim Simons fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Jim Simons's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Jim Simons opened 584 new positions and closed 596 in Q2 2020.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.